It has been shown from prior studies that the p53 pathway is associated with many cancers, where p53 can be indirectly inactivated when MDM2 is overexpressed, PTEN or INK4A/ARF is mutated, the Akt pathway is deregulated, and other events occur [33]. The gene discussed is CDKN2A; the disease is cancer.